HealthLeaders Media February 1, 2024
With newfound authority granted by the IRA, HHS bids on 10 drugs selected for the first round of negotiations.
KEY TAKEAWAYS
– The negotiations are expected to be drawn out over several months and finalized by August 1, with the new prices taking effect in 2026.
– Several drug makers have filed lawsuits challenging the mandate that gives Medicare the power to leverage its unmatched buying power to negotiate directly with drug makers.
– PhRMA spokesman Alex Schriver called the negotiations ‘an exercise to win political points on the campaign trail rather than do what’s in the best interest of patients.’
The federal government on Thursday offered its opening bid for mandated discounts on 10 pricey but widely used drugs...
Today's Sponsors
Today's Sponsor